jmi8b6i | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/4jmi8b6i_hasAnnotation_C0024299> <https://research.tib.eu/covid-19/entity/4jmi8b6i_hasAnnotation_C5203676>
?:creator	<https://research.tib.eu/covid-19/entity/Betrains%2C_Albrecht%3B_Godinas%2C_Laurent%3B_Woei-A-Jin%2C_F_J_Sherida_H%3B_Rosseels%2C_Wouter%3B_Van_Herck%2C_Yannick%3B_Lorent%2C_Natalie%3B_Dierickx%2C_Daan%3B_Compernolle%2C_Veerle%3B_Meyfroidt%2C_Geert%3B_Vanderbeke%2C_Lore%3B_Vergote%2C_Valentijn%3B_Lagrou%2C_Katrien%3B_Verhamme%2C_Peter%3B_Wauters%2C_Joost%3B_Vermeersch%2C_Pieter%3B_Devos%2C_Timothy%3B_Maes%2C_Piet%3B_Vanderschueren%2C_Steven>
?:doi	<https://research.tib.eu/covid-19/entity/10.1111/bjh.17266>
?:doi	10.1111/bjh.17266
?:journal	British_journal_of_haematology
?:license	unk
?:pmid	<https://research.tib.eu/covid-19/entity/33314018.0>
?:pmid	33314018.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:source	Medline
?:title	Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies.
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-12-13

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/4jmi8b6i>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/4jmi8b6i>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all